Results 31 to 40 of about 369 (144)

Tofisopam

open access: yesReactions Weekly, 2019
openaire   +2 more sources

New and emerging therapies in gout

open access: yesRheumatology &Autoimmunity, Volume 3, Issue 2, Page 70-77, June 2023., 2023
Evolution of gout therapy and newer drugs for gout. Abstract Gout is a disease that has been pestering humankind for centuries. Hence, gout therapeutics has always been a field of ongoing research. Beginning from colchicine, which was the first drug to come into use, to the latest inflammasome inhibitors and monoclonal antibodies, therapies for gout ...
Reeta James, Binoy J. Paul
wiley   +1 more source

Current status and features of antipsychotic prescriptions in Japanese forensic psychiatric wards based on a forensic inpatient database. [PDF]

open access: yesNeuropsychopharmacol Rep
We analyzed the current status of antipsychotics for Japanese forensic inpatients with schizophrenia spectrum disorders nationwide. Olanzapine was the most commonly prescribed antipsychotic, followed by clozapine. Clozapine was associated with longer hospitalization and a higher rate of seclusion experience.
Takeda K   +9 more
europepmc   +2 more sources

New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community‐Based Solutions

open access: yesJournal of Chemistry, Volume 2023, Issue 1, 2023., 2023
Across communities worldwide, various new psychoactive substances (NPSs) continue to emerge, which worsens the challenges to global mental health, drug rules, and public health risks, as well as combats their usage. Specifically, the vast number of NPSs that are currently available, coupled with the rate at which new ones emerge worldwide, increasingly
Chinaza Godswill Awuchi   +7 more
wiley   +1 more source

Psychotropic drug use rate among detention house residents and association with the category of the crimes in Japan

open access: yesNeuropsychopharmacology Reports, Volume 41, Issue 4, Page 464-470, December 2021., 2021
In total, 26.5% of the residents in a detention house used psychotropic drugs. The psychotropic drug use rate was 16.7% (excluding the sleeping pill use rate). The use rates of sleeping pills, anxiolytics, antidepressants, and antipsychotics were 22.6%, 11.1%, 3.0%, and 9.6%, respectively.
Akihiro Nishio
wiley   +1 more source

The drug efficacy of tofisopam in an elderly woman.

open access: yesRinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1991
SHIN'ICHI KAKUTA
openaire   +3 more sources

Current state of hypnotic use disorders: Results of a survey using the Japanese version of Benzodiazepine Dependence Self‐Report Questionnaire

open access: yesNeuropsychopharmacology Reports, Volume 41, Issue 1, Page 14-25, March 2021., 2021
Using the Bendep‐SRQ‐J, we elucidated the current state of BZ‐RA dependence. Nearly half of the patients were non‐compliant. Abstract Aims Benzodiazepine receptor agonists (BZ‐RAs) are frequently prescribed to treat insomnia; however, their long‐term use is not recommended.
Mai Yamamoto   +16 more
wiley   +1 more source

Different Techniques for the Determination of Tofisopam

open access: yesJournal of AOAC INTERNATIONAL, 2014
Abstract Five simple and sensitive methods were developed for the determination of tofisopam (TF). The first four are stability-indicating depending on the determination of TF in the presence of its degradation product, while the fifth depended on thedetermination of TF via its degradation product.
Nesrin K, Ramadan   +3 more
openaire   +2 more sources

Potential Cytochrome P450 Drug‐Drug Interaction Among Adult and Adolescent Patients Undergoing Tonsillectomy

open access: yesOTO Open, Volume 4, Issue 2, April‐June 2020., 2020
Objective To assess the frequency of potential drug‐drug interactions affecting cytochrome P450 (CYP)–mediated metabolism of opioids among adult and adolescent patients who underwent adenotonsillectomy. Study Design Retrospective chart review. Setting Tertiary care university hospital.
Sai Nimmagadda   +4 more
wiley   +1 more source

Tofisopam Treatment of Patients with Vertigo and Dizziness.

open access: yesEquilibrium Research, 1992
The therapeutic effect of Tofisopam (150 mg/ day p.o) was evaluated in 39 patients with vertigo or dizziness. The subjective symptoms and objective findings were recorded before and four and eight, weeks after the start of treatment. After eight weeks there was marked improvement in 30.6%, moderate improvement in 19.4%, slight improvement in 41.7%, and
Akisada, Takeshi   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy